Omega Healthcare Investors, Inc. $OHI Shares Sold by Edgestream Partners L.P.

Edgestream Partners L.P. cut its holdings in Omega Healthcare Investors, Inc. (NYSE:OHI) by 61.8% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 94,381 shares of the real estate investment trust’s stock after selling 152,743 shares during the quarter. Edgestream Partners L.P.’s holdings in Omega Healthcare Investors were worth $3,459,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in OHI. Caitong International Asset Management Co. Ltd purchased a new position in shares of Omega Healthcare Investors during the second quarter worth about $26,000. CENTRAL TRUST Co lifted its position in Omega Healthcare Investors by 1,654.4% during the 2nd quarter. CENTRAL TRUST Co now owns 1,000 shares of the real estate investment trust’s stock worth $37,000 after acquiring an additional 943 shares during the period. Cullen Frost Bankers Inc. purchased a new position in shares of Omega Healthcare Investors in the 2nd quarter valued at approximately $41,000. Bayforest Capital Ltd increased its holdings in shares of Omega Healthcare Investors by 395.2% in the second quarter. Bayforest Capital Ltd now owns 1,129 shares of the real estate investment trust’s stock valued at $41,000 after purchasing an additional 901 shares during the period. Finally, Elevation Point Wealth Partners LLC acquired a new position in shares of Omega Healthcare Investors in the second quarter valued at approximately $63,000. 65.25% of the stock is owned by hedge funds and other institutional investors.

Omega Healthcare Investors Trading Down 0.8%

Shares of OHI opened at $45.66 on Thursday. Omega Healthcare Investors, Inc. has a twelve month low of $35.04 and a twelve month high of $46.22. The company has a current ratio of 7.11, a quick ratio of 7.11 and a debt-to-equity ratio of 0.95. The firm has a market capitalization of $13.49 billion, a P/E ratio of 25.51, a PEG ratio of 2.04 and a beta of 0.56. The firm’s 50-day moving average is $42.47 and its two-hundred day moving average is $40.28.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings results on Thursday, October 30th. The real estate investment trust reported $0.79 EPS for the quarter, topping the consensus estimate of $0.77 by $0.02. The business had revenue of $311.59 million for the quarter, compared to analyst estimates of $262.48 million. Omega Healthcare Investors had a return on equity of 10.72% and a net margin of 46.83%.The company’s quarterly revenue was up 14.4% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.71 EPS. Omega Healthcare Investors has set its FY 2025 guidance at 3.080-3.100 EPS. On average, research analysts predict that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, November 17th. Shareholders of record on Monday, November 3rd were issued a $0.67 dividend. The ex-dividend date of this dividend was Monday, November 3rd. This represents a $2.68 annualized dividend and a yield of 5.9%. Omega Healthcare Investors’s dividend payout ratio is 149.72%.

Insiders Place Their Bets

In other news, CEO C Taylor Pickett purchased 20,000 shares of the business’s stock in a transaction dated Wednesday, November 5th. The stock was acquired at an average price of $43.14 per share, with a total value of $862,800.00. Following the purchase, the chief executive officer directly owned 20,000 shares of the company’s stock, valued at $862,800. This represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CIO Vikas Gupta acquired 11,500 shares of the stock in a transaction that occurred on Thursday, November 6th. The stock was acquired at an average cost of $42.97 per share, for a total transaction of $494,155.00. Following the completion of the purchase, the executive owned 13,773 shares in the company, valued at $591,825.81. The trade was a 505.94% increase in their position. The SEC filing for this purchase provides additional information. Company insiders own 1.50% of the company’s stock.

Analyst Upgrades and Downgrades

OHI has been the topic of a number of analyst reports. Mizuho lifted their price objective on shares of Omega Healthcare Investors from $37.00 to $40.00 and gave the company a “neutral” rating in a research report on Thursday, September 11th. Weiss Ratings restated a “buy (b)” rating on shares of Omega Healthcare Investors in a research note on Wednesday, October 8th. Scotiabank boosted their price target on shares of Omega Healthcare Investors from $42.00 to $45.00 and gave the stock a “sector perform” rating in a research note on Thursday, November 13th. Raymond James Financial reissued an “outperform” rating on shares of Omega Healthcare Investors in a report on Tuesday, September 2nd. Finally, Cantor Fitzgerald assumed coverage on Omega Healthcare Investors in a report on Wednesday, October 1st. They issued an “overweight” rating and a $50.00 price objective on the stock. Seven analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $46.44.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.